MELBOURNE, Australia–(BUSINESS WIRE)–#fintech—Charles River® Development, a State Street company, announced that Krungsri Asset Management Co Ltd.…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
ALPHABET ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Alphabet Inc. and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#A–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that…
Guardforce Security Adopts Hytera Push-to-talk to Improve Operational Efficiency
BANGKOK–(BUSINESS WIRE)–#CommunicationSolutions–Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, has…
Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials
Updated results from phase 1 trial, including first presentation of data from a cohort of patients…
Attentive Launches in APAC Region as Global Expansion Continues
SMS-first platform leader opens in Australia to empower brands to create personalised experiences and drive revenue…
Media Alert: BrainChip Illustrates AIoT Readiness at the Edge Impulse ML Series
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first commercial…
LEO Pharma Presents Late-Breaking Positive Phase 3 Results of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (CHE) at AAD 2023
Results demonstrated that delgocitinib cream provided statistically significant improvements in primary and all key secondary endpoints,…
AAD 2023: Late-Breaking Phase III Results Demonstrate nemolizumab’s Significant Impact on Prurigo Nodularis
Extensive updates from broad and innovative portfolio also to be presented The 2023 American Academy of…
Incyte Announces Long-Term Extension Data from Phase 3 TRuE-V Program Demonstrating Long-Term Safety and Durability of Response of Opzelura® (Ruxolitinib) Cream in Vitiligo
– Patients achieving a high level of facial repigmentation (≥F-VASI90) at Week 52 maintained durable response…
University of Phoenix College of Doctoral Studies Releases Whitepaper on Reskilling and Upskilling to Empower Employee Potential
Author Dr. Erik Bean shares insights on opportunities in education for talent development PHOENIX–(BUSINESS WIRE)–University of…